Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 15/20 | 0.55 |
| ▸ | HTR2A | P28223 | 15/20 | 0.55 |
| ▸ | HTR1A | P08908 | 14/20 | 0.55 |
| ▸ | HTR2C | P28335 | 4/20 | 0.55 |
| ▸ | ADRA1A | P35348 | 4/20 | 0.55 |
| ▸ | HRH1 | P35367 | 4/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4574716 | 0.90 | DRD2 (0.58) | DRD2HTR2AHTR1AHTR2CADRA1A | |
| Hydrochloric Acid SCHEMBL4574818 | 0.89 | DRD2 (0.57) | DRD2HTR2AHTR1AHTR2CADRA1A | |
| SCHEMBL4574843 | 0.88 | DRD2 (0.58) | DRD2HTR2AHTR1AHTR2CADRA1A | |
| Hydrochloric Acid SCHEMBL4575077 | 0.87 | DRD2 (0.55) | DRD2HTR2AHTR1AHTR2CADRA1A | |
| Hydrochloric Acid SCHEMBL4574922 | 0.87 | DRD2 (0.57) | DRD2HTR2AHTR1AHTR2CADRA1A | |
| SCHEMBL4574365 | 0.85 | DRD2 (0.55) | DRD2HTR2AHTR1AHTR2CADRA1A | |
| Hydrochloric Acid SCHEMBL4574992 | 0.84 | DRD2 (0.54) | DRD2HTR2AHTR1AHTR2CADRA1A | |
| Hydrochloric Acid SCHEMBL4574995 | 0.84 | DRD2 (0.56) | DRD2HTR2AHTR1AHTR2CADRA1A | |
| SCHEMBL29433199 | 0.82 | DRD2 (0.75) | DRD2HTR2AHTR1AHTR2CADRA1A | |
| SCHEMBL4574903 | 0.81 | DRD2 (0.57) | DRD2HTR2AHTR1AHTR2CADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008047883-A1 | PIPERAZINE-SUBSTITUTED BENZOTHIOPHENES FOR TREATMENT OF MENTAL DISORDERS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2008-04-24 | — | — | WO | claimed |